Manufacturer record
Astonea Labs Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Astonea Labs Pvt. Ltd (Haryana) were declared Not of Standard Quality between December 2024 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Astonea Labs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pregabalin IP 75mg, Nortripyline 10mg and Methylcobalamin IP 1500mcg, | ADT252729AMfg 2025-10 · Exp 2027-09 | The content of Methylcobalamin found to be 668.61 mcg per tablet (44.574%) against labelled claim of 1500 mcg per tablet.Labelling | Govt Analyst PunjabState lab | Jul 2026 |
| Levetiracetam Tablets IP 1000mg | ADT251795Mfg 2025-06 · Exp 2027-05 | The sample is found Not of Standard Quality for the reason stated under Description as per Schedule V of Drugs and Cosmetic Acts and Rules.Description | CDL KolkataCDSCO lab | Jun 2026 |
| Ketoconazole Soap 2% w/w) | ADE25561Mfg 2025-05 · Exp 2027-04 | Assay ketoconazoleAssay | RDTL, Bellary, KarnatakaState lab | Mar 2026 |
| Atorvastatin, Aspirin & Clopidogrel Capsules s | ADH24148AMfg 2024-10 · Exp 2026-09 | Test free Salycylic AcidOther | MaharashtraState lab | Feb 2026 |
| Aceclofenac & Paracetamol Tablets | ADT24078CMfg 2024-03 · Exp 2026-02 | The sample does not conform to the claim with respect to Colour as it shows the presence of Sunset Yellow.Description | DTL UdaipurState lab | Feb 2026 |
| Sodium Valproate & Valproic Acid Controlled Release Tablets | ADT25196BMfg 2025-01 · Exp 2026-12 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium ValproateAssay | RDTL,ChandigarhCDSCO lab | Nov 2025 |
| (Povidone Iodine Ointment USP 5% W/W) | ADE25105Mfg 2025-01 · Exp 2026-12 | Assay for Available IodineAssay | DTL, Bengaluru, KarnatakaState lab | Nov 2025 |
| Teneligliptin & Metformin Hydrochloride (Sustained Release) Tablets IP (Teglisure-M 500) | AOT244-00BMfg 2024-03 · Exp 2026-02 | Assay/content of TeneligliptinAssay | CDL KolkataCDSCO lab | Apr 2025 |
| Ramipril & Metoprolol Succinate Tablets (Ramigan -MT 2.5/ 25 Tablets) | AOT23322Mfg 2023-06 · Exp 2025-05 | "Assay of Ramipril"Assay | CDTL MumbaiCDSCO lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.